These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2475344)

  • 21. Prostate specific antigen--a screening test for prostatic cancer?
    Powell CS; Fielding AM; Rosser K; Ames AC; Vaughton KC
    Br J Urol; 1989 Nov; 64(5):504-6. PubMed ID: 2482112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate.
    Stamey TA; Yang N; Hay AR; McNeal JE; Freiha FS; Redwine E
    N Engl J Med; 1987 Oct; 317(15):909-16. PubMed ID: 2442609
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prostate-specific antigen. A new marker of prostatic pathology].
    Boccon-Gibod L; Géraud M; Dugué MA
    Ann Urol (Paris); 1988; 22(3):206-10. PubMed ID: 2456714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of transurethral prostatectomy on serum prostate specific antigen.
    Vesey SG; Goble NM; Stower MJ; Hammonds JC; Smith PJ
    Br J Urol; 1988 Oct; 62(4):347-51. PubMed ID: 2461243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical usefulness of prostate-specific antigen and prostatic acid phosphatase in patients with prostatic cancer.
    Filella X; Molina R; Jo J; Umbert B; Bedini JL; Ballesta AM
    Tumour Biol; 1990; 11(6):289-94. PubMed ID: 1700860
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Anatomoclinical and biologic correlations in prostatic pathology. Apropos of 150 case reports].
    Amiel J; Chevallier D; Peyrottes A; Benoliel J; Toubol J
    Ann Urol (Paris); 1989; 23(6):528-30. PubMed ID: 2482700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The diagnostic value of urinary transferrin compared to serum prostatic specific antigen (PSA) and prostatic acid phosphatase (PAP) in patients with prostatic cancer.
    van Dieijen-Visser MP; Hendriks MW; Delaere KP; Gijzen AH; Brombacher PJ
    Clin Chim Acta; 1988 Sep; 177(1):77-80. PubMed ID: 2460272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [PSA in prostatic fluid].
    Lehmann K; Simmler F; Schmucki O; Hauri D
    Urologe A; 1994 May; 33(3):232-4. PubMed ID: 7519804
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Tumor markers of prostate cancer--evaluation of serum PAP and PA].
    Miki M
    Gan No Rinsho; 1985 May; 31(6 Suppl):664-9. PubMed ID: 2411965
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The usefulness of prostate-specific antigen and prostatic acid phosphatase in clinical practice.
    Daver A; Soret JY; Coblentz Y; Allain YM; Cellier P; Chauveau P
    Am J Clin Oncol; 1988; 11 Suppl 2():S53-60. PubMed ID: 2468273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostate-specific antigen in prostatic cancer.
    Baron JC; Peyret C; Leroy M; Teillac P; Najean Y; Le Duc A
    Am J Clin Oncol; 1988; 11 Suppl 2():S75-6. PubMed ID: 2468279
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum prostate-specific antigen determination in prostatic carcinoma.
    Tizzani A; Casetta G; Piana P; Bellina M; Pecchio F; Aimo G; Adamo R
    Int J Biol Markers; 1987; 2(3):184-6. PubMed ID: 2453594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The value of the measurement of serum prostate specific antigen in patients with benign prostatic hyperplasia and untreated prostate cancer.
    Armitage TG; Cooper EH; Newling DW; Robinson MR; Appleyard I
    Br J Urol; 1988 Dec; 62(6):584-9. PubMed ID: 2464397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of prostate volume on the ratio of free to total prostate specific antigen in serum of patients with prostate carcinoma and benign prostate hyperplasia.
    Stephan C; Lein M; Jung K; Schnorr D; Loening SA
    Cancer; 1997 Jan; 79(1):104-9. PubMed ID: 8988733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostate tumour markers as an aid in the staging of prostatic cancer.
    Haapiainen RK; Permi EJ; Rannikko SA; Voutilainen PE; Liewendahl K; Stenman UH; Alfthan OS
    Br J Urol; 1990 Mar; 65(3):264-7. PubMed ID: 1692497
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An evaluation of the immunochemical measurement of prostatic acid phosphatase and prostatic specific antigen in carcinoma of the prostate.
    Siddall JK; Cooper EH; Newling DW; Robinson MR; Whelan P
    Eur Urol; 1986; 12(2):123-30. PubMed ID: 2420600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative experimental study of the serum prostate specific antigen and prostatic acid phosphatase in serially transplantable human prostatic carcinoma lines in nude mice.
    Csapo Z; Brand K; Walther R; Fokas K
    J Urol; 1988 Nov; 140(5):1032-8. PubMed ID: 2459419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantification of prostatic cancer metastatic disease using prostate-specific antigen.
    Vesey SG; Goble M; Ferro MA; Stower MJ; Hammonds JC; Smith PJ
    Urology; 1990 Jun; 35(6):483-6. PubMed ID: 1693796
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostate specific antigen and prostatic acid phosphatase for monitoring therapy of carcinoma of the prostate.
    Dupont A; Cusan L; Gomez JL; Thibeault MM; Tremblay M; Labrie F
    J Urol; 1991 Oct; 146(4):1064-7; discussion 1067-8. PubMed ID: 1716697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variation of prostate-specific antigen expression in different tumour growth patterns present in prostatectomy specimens.
    Gallee MP; Visser-de Jong E; van der Korput JA; van der Kwast TH; ten Kate FJ; Schroeder FH; Trapman J
    Urol Res; 1990; 18(3):181-7. PubMed ID: 1697709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.